CRISP3 and prostate carcinoma: We also aimed to validate the prognostic value of CRISP3 in conjunction to the molecular subtype of PCA with ERG and PTEN genomic aberrations and to utilize bioinformatics to delineate possible genetic connections and pathways related to this molecular subtype of prostate cancer.